• Dexco executive officers met Aug. 5, 2026 to resolve on interim financial statements for the quarter ended June 30, 2026.
• Board resolved it had reviewed, discussed, and agreed with the interim individual and consolidated accounting information for the period.
• Board also resolved it agreed with Ernst & Young’s review report on the quarterly information, which concluded no material departures from NBC TG 21 and IAS 34.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexco SA published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.